Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Sep 18, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bicara Therapeutics Inc.
| 6.96M |
$18.00 | $32,994,000.00 | +135.78% | 12.08M |
Sep 16
| |||||||
Bicara Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 12
| |||||||
Bicara Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Fulcrum Therapeutics, Inc.
| -8.50M |
—
|
—
| -73.21% | 3.11M |
Aug 21
| |||||||
Wave Life Sciences Ltd.
| 16.11K |
—
|
—
|
∞
| 16.11K |
Aug 12
| |||||||
An2 Therapeutics, Inc.
| -3.53M |
$1.08 | -$3,807,101.52 | -63.50% | 2.03M |
Aug 9
| |||||||
Artiva Biotherapeutics, Inc.
| 9.85M |
$11.10 | $104,709,203.40 | +515.21% | 11.77M |
Jul 22
| |||||||
Cidara Therapeutics, Inc.
| 703.08K |
—
|
—
|
∞
| 703.08K |
Jul 18 - Jul 19
| |||||||
Cidara Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 18
| |||||||
Cidara Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 18
| |||||||
Artiva Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Eliem Therapeutics, Inc.
| 18.27M |
$3.84 | $49,952,816.64 | +76.18% | 42.25M |
Jun 27
| |||||||
Eliem Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 26
| |||||||
Janux Therapeutics, Inc.
| 2.5K |
—
|
—
|
∞
| 2.5K |
Jun 26
| |||||||
Acrivon Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
Ars Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
Pepgen Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
Aerovate Therapeutics, Inc.
| 928.11K |
$1.67 | $1,549,943.70 | +13.32% | 7.89M |
Jun 17
| |||||||
Nkarta, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 13
| |||||||
Acumen Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Aerovate Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 5
| |||||||
Tyra Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 29
| |||||||
Mineralys Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 22
| |||||||
Vor Biopharma Inc.
|
0
|
—
|
—
|
—
|
0
|
May 23
| |||||||
Werewolf Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 24
| |||||||
Iteos Therapeutics, Inc.
| -900.00K |
—
|
—
| -26.12% | 2.55M |
May 10 - May 12
| |||||||
Cidara Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Apr 26
| |||||||
Cidara Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
89bio, Inc.
| 1.41M |
$5.33 | $7,499,996.25 | +11.33% | 13.84M |
Feb 9 - Apr 11
| |||||||
Acrivon Therapeutics, Inc.
| 3.53M |
$8.50 | $30,005,000.00 | +80.52% | 7.91M |
Apr 11
| |||||||
Boundless Bio, Inc.
| 2.18M |
$16.00 |
—
|
∞
| 2.18M |
Apr 2
| |||||||
Nkarta, Inc.
| 3M |
$10.00 | $30,000,000.00 | +42.55% | 10.05M |
Mar 27
| |||||||
Boundless Bio, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Ars Pharmaceuticals, Inc.
| 1.4M |
$9.48 | $13,289,410.41 | +16.38% | 9.96M |
Mar 25 - Mar 27
| |||||||
Lenz Therapeutics, Inc.
| 4.24M |
$15.03 | $15,000,075.27 | +140.71% | 7.26M |
Mar 21
| |||||||
Lenz Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
89bio, Inc.
| 1.35M |
$15.35 | $20,722,500.00 | +12.18% | 12.43M |
Mar 4
| |||||||
Janux Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 4
| |||||||
Icosavax, Inc.
| -5.97M |
—
|
—
| -100.00% |
0
|
Feb 19
| |||||||
Mineralys Therapeutics, Inc.
| 1.67M |
$13.50 | $22,578,858.00 | +127.55% | 2.98M |
Feb 12
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.